Sarkom
Publikasjoner
2021
1. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
Stacchiotti S, Miah AB, Frezza AM, Messiou C, Morosi C, Caraceni A, Antonescu CR, Bajpai J, Baldini E, Bauer S, Biagini R, Bielack S, Blay JY, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Callegaro D, De Alava E, Deoras-Sutliff M, Dufresne A, Eriksson M, Errani C, Fedenko A, Ferraresi V, Ferrari A, Fletcher CDM, Garcia Del Muro X, Gelderblom H, Gladdy RA, Gouin F, Grignani G, Gutkovich J, Haas R, Hindi N, Hohenberger P, Huang P, Joensuu H, Jones RL, Jungels C, Kasper B, Kawai A, Le Cesne A, Le Grange F, Leithner A, Leonard H, Lopez Pousa A, Martin Broto J, Merimsky O, Merriam P, Miceli R, Mir O, Molinari M, Montemurro M, Oldani G, Palmerini E, Pantaleo MA, Patel S, Piperno-Neumann S, Raut CP, Ravi V, Razak ARA, Reichardt P, Rubin BP, Rutkowski P, Safwat AA, Sangalli C, Sapisochin G, Sbaraglia M, Scheipl S, Schöffski P, Strauss D, Strauss SJ, Sundby Hall K, Tap WD, Trama A, Tweddle A, van der Graaf WTA, Van De Sande MAJ, Van Houdt W, van Oortmerssen G, Wagner AJ, Wartenberg M, Wood J, Zaffaroni N, Zimmermann C, Casali PG, Dei Tos AP, Gronchi A.
ESMO Open. 2021 Jun;6(3):100170. doi: 10.1016/j.esmoop.2021.100170. Epub 2021 Jun 2.
PMID: 34090171 Free PMC article. Review.
2. Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour.
Georgiesh T, Namløs HM, Sharma N, Lorenz S, Myklebost O, Bjerkehagen B, Meza-Zepeda LA, Boye K.
Pathology. 2021 Oct;53(6):713-719. doi: 10.1016/j.pathol.2020.11.010. Epub 2021 Mar 19.
PMID: 33745702
3. Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.
Boye K, Longhi A, Guren T, Lorenz S, Næss S, Pierini M, Taksdal I, Lobmaier I, Cesari M, Paioli A, Løndalen AM, Setola E, Hompland I, Meza-Zepeda LA, Sundby Hall K, Palmerini E.
Cancer Immunol Immunother. 2021 Sep;70(9):2617-2624. doi: 10.1007/s00262-021-02876-w. Epub 2021 Feb 12.
PMID: 33580363 Free PMC article. Clinical Trial.
4. Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.
Peneder P, Stütz AM, Surdez D, Krumbholz M, Semper S, Chicard M, Sheffield NC, Pierron G, Lapouble E, Tötzl M, Ergüner B, Barreca D, Rendeiro AF, Agaimy A, Boztug H, Engstler G, Dworzak M, Bernkopf M, Taschner-Mandl S, Ambros IM, Myklebost O, Marec-Bérard P, Burchill SA, Brennan B, Strauss SJ, Whelan J, Schleiermacher G, Schaefer C, Dirksen U, Hutter C, Boye K, Ambros PF, Delattre O, Metzler M, Bock C, Tomazou EM.
Nat Commun. 2021 May 28;12(1):3230. doi: 10.1038/s41467-021-23445-w.
PMID: 34050156 Free PMC article.
5. Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach.
Hølmebakk T, Wiedswang AM, Meza-Zepeda LA, Hompland I, Lobmaier IVK, Berner JM, Stoldt S, Boye K.
Ann Surg Oncol. 2021 Oct;28(11):6837-6845. doi: 10.1245/s10434-021-09605-8. Epub 2021 Mar 2.
PMID: 33651216 Free PMC article.
6. Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dufresne A, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Frezza AM, Gasperoni S, Gelderblom H, Gouin F, Grignani G, Haas R, Hassan AB, Hindi N, Hohenberger P, Joensuu H, Jones RL, Jungels C, Jutte P, Kasper B, Kawai A, Kopeckova K, Krákorová DA, Le Cesne A, Le Grange F, Legius E, Leithner A, Lopez-Pousa A, Martin-Broto J, Merimsky O, Messiou C, Miah AB, Mir O, Montemurro M, Morosi C, Palmerini E, Pantaleo MA, Piana R, Piperno-Neumann S, Reichardt P, Rutkowski P, Safwat AA, Sangalli C, Sbaraglia M, Scheipl S, Schöffski P, Sleijfer S, Strauss D, Strauss SJ, Hall KS, Trama A, Unk M, van de Sande MAJ, van der Graaf WTA, van Houdt WJ, Frebourg T, Gronchi A, Stacchiotti S; ESMO Guidelines Committee, EURACAN and GENTURIS. Electronic address: clinicalguidelines@esmo.org.
Ann Oncol. 2022 Jan;33(1):20-33. doi: 10.1016/j.annonc.2021.09.005. Epub 2021 Sep 21.
PMID: 34560242 No abstract available.
7. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.
Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brennan B, Brodowicz T, Buonadonna A, De Álava E, Del Muro XG, Dufresne A, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Frezza AM, Gasperoni S, Gelderblom H, Gouin F, Grignani G, Haas R, Hassan AB, Hecker-Nolting S, Hindi N, Hohenberger P, Joensuu H, Jones RL, Jungels C, Jutte P, Kager L, Kasper B, Kawai A, Kopeckova K, Krákorová DA, Le Cesne A, Le Grange F, Legius E, Leithner A, Lopez-Pousa A, Martin-Broto J, Merimsky O, Messiou C, Mir O, Montemurro M, Morland B, Morosi C, Palmerini E, Pantaleo MA, Piana R, Piperno-Neumann S, Reichardt P, Rutkowski P, Safwat AA, Sangalli C, Sbaraglia M, Scheipl S, Schöffski P, Sleijfer S, Strauss D, Strauss S, Sundby Hall K, Trama A, Unk M, van de Sande MAJ, van der Graaf WTA, van Houdt WJ, Frebourg T, Casali PG, Stacchiotti S; ESMO Guidelines Committee, EURACAN and GENTURIS. Electronic address: clinicalguidelines@esmo.org.
Ann Oncol. 2021 Nov;32(11):1348-1365. doi: 10.1016/j.annonc.2021.07.006. Epub 2021 Jul 22.
PMID: 34303806 No abstract available.
8. Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.
Strauss SJ, Frezza AM, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brennan B, Brodowicz T, Buonadonna A, de Álava E, Dei Tos AP, Garcia Del Muro X, Dufresne A, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Gaspar N, Gasperoni S, Gelderblom H, Gouin F, Grignani G, Gronchi A, Haas R, Hassan AB, Hecker-Nolting S, Hindi N, Hohenberger P, Joensuu H, Jones RL, Jungels C, Jutte P, Kager L, Kasper B, Kawai A, Kopeckova K, Krákorová DA, Le Cesne A, Le Grange F, Legius E, Leithner A, López Pousa A, Martin-Broto J, Merimsky O, Messiou C, Miah AB, Mir O, Montemurro M, Morland B, Morosi C, Palmerini E, Pantaleo MA, Piana R, Piperno-Neumann S, Reichardt P, Rutkowski P, Safwat AA, Sangalli C, Sbaraglia M, Scheipl S, Schöffski P, Sleijfer S, Strauss D, Sundby Hall K, Trama A, Unk M, van de Sande MAJ, van der Graaf WTA, van Houdt WJ, Frebourg T, Ladenstein R, Casali PG, Stacchiotti S; ESMO Guidelines Committee, EURACAN, GENTURIS and ERN PaedCan. Electronic address: clinicalguidelines@esmo.org.
Ann Oncol. 2021 Dec;32(12):1520-1536. doi: 10.1016/j.annonc.2021.08.1995. Epub 2021 Sep 6.
PMID: 34500044 No abstract available.
9. ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
Hølmebakk T, Boye K.
Ann Surg Oncol. 2021 Oct;28(11):6846-6847. doi: 10.1245/s10434-021-09608-5. Epub 2021 Mar 9.
PMID: 33687615 Free PMC article. No abstract available.
10. Correction to: ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
Hølmebakk T, Boye K.
Ann Surg Oncol. 2021 Dec;28(Suppl 3):873. doi: 10.1245/s10434-021-09939-3.
PMID: 33829360 No abstract available.
11. Chondrosarcoma local recurrence in the Cancer Registry of Norway cohort (1990-2013): Patterns and impact.
Thorkildsen J, Norum OJ, Myklebust TA, Zaikova O.J Surg Oncol. 2021 Feb;123(2):510-520. doi: 10.1002/jso.26308. Epub 2020 Dec 14.PMID: 33314135
12. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
van Atteveld JE, Mulder RL, van den Heuvel-Eibrink MM, Hudson MM, Kremer LCM, Skinner R, Wallace WH, Constine LS, Higham CE, Kaste SC, Niinimäki R, Mostoufi-Moab S, Alos N, Fintini D, Templeton KJ, Ward LM, Frey E, Franceschi R, Pavasovic V, Karol SE, Amin NL, Vrooman LM, Harila-Saari A, Demoor-Goldschmidt C, Murray RD, Bardi E, Lequin MH, Faienza MF, Zaikova O, Berger C, Mora S, Ness KK, Neggers SJCMM, Pluijm SMF, Simmons JH, Di Iorgi N.Lancet Diabetes Endocrinol. 2021 Sep;9(9):622-637. doi: 10.1016/S2213-8587(21)00173-X. Epub 2021 Jul 30.PMID: 34339631 Review.
2020
1. Cell-free DNA in blood as a noninvasive insight into the sarcoma genome. Namløs HM, Boye K, Meza-Zepeda LA.Mol Aspects Med. 2020 Apr;72:100827. doi: 10.1016/j.mam.2019.10.004. Epub 2019 Nov 6.
PMID: 31703948 Review.
2. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network. Demetri GD, Antonescu CR, Bjerkehagen B, Bovée JVMG, Boye K, Chacón M, Dei Tos AP, Desai J, Fletcher JA, Gelderblom H, George S, Gronchi A, Haas RL, Hindi N, Hohenberger P, Joensuu H, Jones RL, Judson I, Kang YK, Kawai A, Lazar AJ, Le Cesne A, Maestro R, Maki RG, Martín J, Patel S, Penault-Llorca F, Premanand Raut C, Rutkowski P, Safwat A, Sbaraglia M, Schaefer IM, Shen L, Serrano C, Schöffski P, Stacchiotti S, Sundby Hall K, Tap WD, Thomas DM, Trent J, Valverde C, van der Graaf WTA, von Mehren M, Wagner A, Wardelmann E, Naito Y, Zalcberg J, Blay JY. Ann Oncol. 2020 Nov;31(11):1506-1517. doi: 10.1016/j.annonc.2020.08.2232. Epub 2020 Sep 3.
PMID: 32891793 Review.
3. Prospects for NK Cell Therapy of Sarcoma. Lachota M, Vincenti M, Winiarska M, Boye K, Zagożdżon R, Malmberg KJ. Cancers (Basel). 2020 Dec 11;12(12):3719. doi: 10.3390/cancers12123719.
PMID: 33322371 Free PMC article. Review.
4. Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS). Palmerini E, Leithner A, Windhager R, Gosheger G, Boye K, Laitinen M, Hardes J, Traub F, Jutte P, Willegger M, Casanova J, Setola E, Righi A, Picci P, Donati DM, Ferrari S. Sci Rep. 2020 Jul 2;10(1):10853. doi: 10.1038/s41598-020-66579-5.
PMID: 32616718 Free PMC article.
5. A novel risk score to predict early and late recurrence in solitary fibrous tumour. Georgiesh T, Boye K, Bjerkehagen B. Histopathology. 2020 Jul;77(1):123-132. doi: 10.1111/his.14078.
PMID: 31991494
6. Risk stratification for central conventional chondrosarcoma of bone: A novel system predicting risk of metastasis and death in the Cancer Registry of Norway cohort. Thorkildsen J, Taksdal I, Bjerkehagen B, Norum OJ, Myklebust TA, Zaikova O. J Surg Oncol. 2020 Jun;121(7):1115-1125. doi: 10.1002/jso.25883. Epub 2020 Mar 5.
PMID: 32141094
7. Chondrosarcoma local recurrence in the Cancer Registry of Norway cohort (1990-2013): Patterns and impact. Thorkildsen J, Norum OJ, Myklebust TA, Zaikova O. J Surg Oncol. 2020 Dec 14. doi: 10.1002/jso.26308. Online ahead of print.
PMID: 33314135
8. Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up. Joensuu H, Eriksson M, Sundby Hall K, Reichardt A, Hermes B, Schütte J, Cameron S, Hohenberger P, Jost PJ, Al-Batran SE, Lindner LH, Bauer S, Wardelmann E, Nilsson B, Kallio R, Jaakkola P, Junnila J, Alvegård T, Reichardt P. JAMA Oncol. 2020 Aug 1;6(8):1241-1246. doi: 10.1001/jamaoncol.2020.2091.
PMID: 32469385 Free PMC article.
9. The Role of Adjuvant Treatment in Craniofacial Malignancy: A Critical Review. König M, Osnes T, Bruland Ø, Sundby Hall K, Bratland Å, Meling TR. Front Oncol. 2020 Aug 7;10:1402. doi: 10.3389/fonc.2020.01402. eCollection 2020.
PMID: 32850452 Free PMC article. Review.
10. [Cardiac sarcoma].
Hamre CFB, Kvammen EMH, Vinge LE, Skeie AT, Hompland I
Tidsskr Nor Laegeforen. 2020 Apr 20;140(6). doi: 10.4045/tidsskr.19.0455. Print 2020 Apr 21.
PMID: 32321220 Norwegian.
11. Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors. Hompland I, Fauske L, Lorem GF, Bruland ØS.Clin Sarcoma Res. 2020 Jan 16;10:2. doi: 10.1186/s13569-019-0124-3. eCollection 2020.
PMID: 31969978 Free PMC article.
12. Striving towards Normality in Daily Life: A Qualitative Study of Patients Living with Metastatic Gastrointestinal Stromal Tumour in Long-Term Clinical Remission. Fauske L, Hompland I, Lorem G, Hall KS, Bondevik H. Sarcoma. 2020 Oct 6;2020:1814394. doi: 10.1155/2020/1814394. eCollection 2020.
PMID: 33082706 Free PMC article.
13. Accurate 3-gene-signature for early diagnosis of liposarcoma progression. Serguienko A, Braadland P, Meza-Zepeda LA, Bjerkehagen B, Myklebost O.Serguienko A, et al. Clin Sarcoma Res. 2020 Mar 5;10:4. doi:
14. FOS-ANKH and FOS-RUNX2 Fusion Genes in Osteoblastoma. Panagopoulos I, Gorunova L, Lobmaier I, Andersen K, Kostolomov I, Lund-Iversen M, Bjerkehagen B, Heim S.Panagopoulos I, et al. Cancer Genomics Proteomics. 2020 Mar-Apr;17(2):161-168. doi: 10.21873/cgp.20176.Cancer Genomics Proteomics. 2020.
PMID: 32108038 Free PMC
15. Chronic Expanding Hematoma with a t(11;19)(q13;q13) Chromosomal Translocation. Panagopoulos I, Gorunova L, Kostolomov I, Lobmaier I, Bjerkehagen B, Heim S.Panagopoulos I, et al. Anticancer Res. 2020 Jan;40(1):97-100. doi: 10.21873/anticanres.13930.Anticancer Res. 2020.
PMID: 31892557
16. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Bailey MH, Meyerson WU, Dursi LJ, Wang LB, Dong G, Liang WW, Weerasinghe A, Li S, Kelso S; MC3 Working Group; PCAWG novel somatic mutation calling methods working group, Saksena G, Ellrott K, Wendl MC, Wheeler DA, Getz G, Simpson JT, Gerstein MB, Ding L; PCAWG Consortium.Bailey MH, et al. Nat Commun. 2020 Sep 21;11(1):4748. doi: 10.1038/s41467-020-18151-y.Nat Commun. 2020.
PMID: 32958763
17. Pan-cancer analysis of whole genomes. ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium.ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5.Nature. 2020.
PMID: 32025007 Free PMC article.
18. Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study.Hall KS, Bruland ØS, Bjerkehagen B, Lidbrink E, Jebsen N, Hagberg H, Papworth K, Hagberg O, Trovik C, Bauer H, Eriksson M. Clin Sarcoma Res. 2020 Nov 17;10(1):22. doi: 10.1186/s13569-020-00145-5.
PMID: 33292545
19. Cytogenetic and Molecular Study of an Adult Sclerosing Rhabdomyosarcoma of the Extremity: MYOD1-mutation and Clonal Evolution.Gorunova L, Bjerkehagen B, Micci F, Heim S, Panagopoulos I.Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):563-569. doi: 10.21873/cgp.20212.
PMID: 32859634
20. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Bonvalot S, Gronchi A, Le Péchoux C, Swallow CJ, Strauss D, Meeus P, van Coevorden F, Stoldt S, Stoeckle E, Rutkowski P, Rastrelli M, Raut CP, Hompes D, De Paoli A, Sangalli C, Honoré C, Chung P, Miah A, Blay JY, Fiore M, Stelmes JJ, Dei Tos AP, Baldini EH, Litière S, Marreaud S, Gelderblom H, Haas RL. Lancet Oncol. 2020 Oct;21(10):1366-1377. doi: 10.1016/S1470-2045(20)30446-0. Epub 2020 Sep 14.
PMID: 32941794 Clinical Trial.
21. Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study. Ree AH, Nygaard V, Boye K, Heinrich D, Dueland S, Bergheim IR, Johansen C, Beiske K, Negård A, Lund-Iversen M, Nygaard V, Hovig E, Nakken S, Nasser S, Julsrud L, Reisse CH, Ruud EA, Kristensen VN, Flørenes VA, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Russnes HG, Mælandsmo GM, Flatmark K (2020). Acta Oncol 59(7):733-740
22. Treating osteosarcoma with CAR T cells. Köksal H, Müller E, Inderberg EM, Bruland Ø, Wälchli S. Scand J Immunol. 2019 Mar;89(3):e12741. doi: 10.1111/sji.12741. Epub 2019 Jan 15.Scand J Immunol. 2019.
PMID: 30549299
23. The sacral chordoma margin. Radaelli S, Fossati P, Stacchiotti S, Akiyama T, Asencio JM, Bandiera S, Boglione A, Boland P, Bolle S, Bruland Ø, Brunello A, Bruzzi P, Campanacci D, Cananzi F, Capanna R, Casadei R, Cordoba A, Court C, Dei Tos AP, DeLaney TF, De Paoli A, De Pas TM, Desai A, Di Brina L, Donati DM, Fabbri N, Fiore MR, Frezza A, Gambarotti M, Gasbarrini A, Georg P, Grignani G, Hindi N, Hug EB, Jones R, Kawai A, Krol AD, Le Grange F, Luzzati A, Marquina G, Martin-Benlloch JA, Mazzocco K, Navarria F, Navarria P, Parchi PD, Patel S, Pennacchioli E, Petrongari MG, Picci P, Pollock R, Porcu L, Quagliuolo V, Sangalli C, Scheipl S, Scotto GM, Spalek M, Steinmeier T, Timmermann B, Trama A, Uhl M, Valverde C, Varga PP, Verges R, Weber DC, Zoccali C, Casali PG, Sommer J, Gronchi A., Radaelli S. Eur J Surg Oncol. 2020 Aug;46(8):1415-1422. doi: 10.1016/j.ejso.2020.04.028. Epub 2020
24. Bone health in cancer: ESMO Clinical Practice Guidelines. Coleman R, Hadji P, Body JJ, Santini D, Chow E, Terpos E, Oudard S, Bruland Ø, Flamen P, Kurth A, Van Poznak C, Aapro M, Jordan K; ESMO Guidelines Committee. Annal of Oncology. 2020 Dec;31(12):1650-1663. doi: 10.1016/j.annonc.2020.07.019.
PMID: 32801018
25. Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial. Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL.Lansu J, et al. JAMA Oncol. 2020 Nov 12:e205865. doi: 10.1001/jamaoncol.2020.5865. Online ahead of print.JAMA Oncol. 2020.
PMID: 33180100
26. Fusion of the COL4A5 Gene With NR2F2-AS1 in a Hemangioma Carrying a t(X;15)(q22;q26) Chromosomal Translocation. Panagopoulos I, Gorunova L, Lobmaier I, Andersen K, Lund-Iversen M, Micci F, Heim S. Cancer Genomics Proteomics. 2020 Jul-Aug;17(4):383-390. doi: 10.21873/cgp.20197.
PMID: 32576583 Free PMC article.
27. Fusion of the Lumican (LUM) Gene With the Ubiquitin Specific Peptidase 6 (USP6) Gene in an Aneurysmal Bone Cyst Carrying a t(12;17)(q21;p13) Chromosome Translocation. Panagopoulos I, Gorunova L, Andersen K, Lobmaier I, Lund-Iversen M, Micci F, Heim S. Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):555-561. doi: 10.21873/cgp.20211.
PMID: 32859633 Free PMC article.
28. Recurrent Fusion of the GRB2 Associated Binding Protein 1 (GAB1) Gene With ABL Proto-oncogene 1 (ABL1) in Benign Pediatric Soft Tissue Tumors. Panagopoulos I, Gorunova L, Andersen K, Tafjord S, Lund-Iversen M, Lobmaier I, Micci F, Heim S. Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):499-508. doi: 10.21873/cgp.20206.
PMID: 32859628 Free PMC article.
2019
Hanes R, Munthe E, Grad I, Han J, Karlsen I, McCormack E, Meza-Zepeda LA, Stratford EW, Myklebost O. Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma. Cells. 2019 Feb 21;8(2). pii: E189. doi: 10.3390/cells8020189.
PubMed PMID: 30795553; PubMed Central PMCID: PMC6406403.
Papworth KE, Arroyo VM, Styring E, Zaikova O, Melin BS, Lupo PJ. Soft-tissue sarcoma in adolescents and young adults compared with older adults: A report among 5000 patients from the Scandinavian Sarcoma Group Central Register. Cancer. 2019 Oct 15;125(20):3595-3602. doi: 10.1002/cncr.32367. Epub 2019 Jul 9.
PubMed PMID: 31287163.
Panagopoulos I, Gorunova L, Lobmaier I, Lund-Iversen M, Andersen K, Holth A, Bjerkehagen B, Heim S. Fusion of the COL1A1 and FYN Genes in Epithelioid Osteoblastoma. Cancer Genomics Proteomics. 2019 Sep-Oct;16(5):361-368. doi: 10.21873/cgp.20141.
PubMed PMID: 31467230; PubMed Central PMCID: PMC6727071.
Jha AK, Neupane P, Pradhan M, Sharma KS, Shrestha S, Sigdel PR, Smeland S,Bruland ØS. Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy. J Glob Oncol. 2019 Mar;5:1-10. doi:10.1200/JGO.19.00015.
PubMed PMID: 30917070; PubMed Central PMCID: PMC6449078.
Berner K, Bruland ØS. Prognostic Impact of Proximal Versus Distal Localization in Extremity Long Bone Osteosarcomas. Anticancer Res. 2019 May;39(5):2459-2466. doi: 10.21873/anticanres.13365.
PubMed PMID: 31092440.
Longhi A, Paioli A, Palmerini E, Cesari M, Abate ME, Setola E, Spinnato P,
Donati D, Hompland I, Boye K. Pazopanib in relapsed osteosarcoma patients: report on 15 cases. Acta Oncol. 2019 Jan;58(1):124-128. doi:
10.1080/0284186X.2018.1503714. Epub 2018 Sep 12.
PubMed PMID: 30207179.
Fauske L, Hompland I, Lorem G, Bondevik H, Bruland ØS. Perspectives on
treatment side effects in patients with metastatic gastrointestinal stromal tumour: a qualitative study. Clin Sarcoma Res. 2019 Apr 30;9:6. doi: 10.1186/s13569-019-0116-3. eCollection 2019.
PubMed PMID: 31061697; PubMed Central PMCID: PMC6492319.
Hølmebakk T, Boye K. Author response to comment on: Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour. Br J Surg. 2019 Jul;106(8):1102-1103. doi: 10.1002/bjs.11245. PubMed
PMID: 31260582.
Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K. Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour. Br J Surg. 2019 Mar;106(4):419-426. doi: 10.1002/bjs.11027. Epub 2018 Dec 3. PubMed PMID: 30507040.
Hølmebakk T, Bjerkehagen B, Lobmaier IVK, Hompland I, Stoldt S, Boye K. Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors? Ann Surg Oncol. 2019 Dec;26(13):4730-4736. doi:10.1245/s10434-019-07813-x. Epub 2019 Sep 13.
PubMed PMID: 31520212.
Namløs HM, Boye K, Meza-Zepeda LA. Cell-free DNA in blood as a noninvasive insight into the sarcoma genome. Mol Aspects Med. 2019 Nov 5. pii: S0098-2997(19)30064-0. doi: 10.1016/j.mam.2019.10.004. [Epub ahead of print]Review.
PubMed PMID: 31703948.
Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB,
Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer.
2019 Mar;109:36-50. doi: 10.1016/j.ejca.2018.11.027. Epub 2019 Jan 25. PubMed
PMID: 30685685; PubMed Central PMCID: PMC6506906.
Berner K, Johannesen TB, Hall KS, Bruland ØS. Clinical epidemiology and
treatment outcomes of spindle cell non-osteogenic bone sarcomas - A nationwide population-based study. J Bone Oncol. 2018 Nov 20;14:002-2. doi: 10.1016/j.jbo.2018.11.002. eCollection 2019 Feb. PubMed PMID: 30568874; PubMed Central PMCID: PMC6290118.
Thorkildsen J, Taksdal I, Bjerkehagen B, Haugland HK, Børge Johannesen T,
Viset T, Norum OJ, Bruland Ø, Zaikova O. Chondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohort. Acta Oncol. 2019 Jan 11:1-10. doi: 10.1080/0284186X.2018.1554260. [Epub ahead of print]
PubMed PMID: 30632866.
Hesla AC, Bruland ØS, Jebsen N, Styring E, Eriksson S, Tsagozis P. Ewing
sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years. J Bone Oncol. 2018 Dec 26;14:100216. doi:10.1016/j.jbo.2018.100216. eCollection 2019 Feb. PubMed PMID: 30666289;
PubMed Central PMCID: PMC6329704.
2018
Kresse SH, Namløs HM, Lorenz S, Berner JM, Myklebost O, Bjerkehagen B,
Meza-Zepeda LA. Evaluation of commercial DNA and RNA extraction methods for high-throughput sequencing of FFPE samples. PLoS One. 2018 May 17;13(5):e0197456 doi: 10.1371/journal.pone.0197456. eCollection 2018. PubMed PMID: 29771965;
PubMed Central PMCID: PMC5957415.
Stormorken AT, Berg T, Norum OJ, Hølmebakk T, Aaberg K, Steigen SE, Grindedal EM. APC mosaicism in a young woman with desmoid type fibromatosis and familialadenomatous polyposis. Fam Cancer. 2018 Oct;17(4):539-543. doi:10.1007/s10689-018-0072-8.
PubMed PMID: 29368261;
PubMed Central PMCID:
PMC6182574.
Berner K, Zaikova O, Johannesen TB, Hall KS, Bruland ØS. Validity and
completeness of the Scandinavian Sarcoma Group Central Register by comparison with a nationwide cohort of patients with osteosarcoma in Norway. J Surg Oncol.2018 Jul;118(1):246-247. doi: 10.1002/jso.25137. PubMed PMID: 30208205.
Berner K, Johannesen TB, Hall KS, Bruland ØS. Clinical epidemiology and
treatment outcomes of spindle cell non-osteogenic bone sarcomas - A nationwide population-based study. J Bone Oncol. 2018 Nov 20;14:002-2. doi:10.1016/j.jbo.2018.11.002. eCollection 2019 Feb.
PubMed PMID: 30568874;
PubMed Central PMCID: PMC6290118.
Frezza AM, Jones RL, Lo Vullo S, Asano N, Lucibello F, Ben-Ami E, Ratan R,
Teterycz P, Boye K, Brahmi M, Palmerini E, Fedenko A, Vincenzi B, Brunello A,Desar IME, Benjamin RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G,Gronchi A, Hall KS, Mir O, Rutkowski P, Wagner AJ, Anurova O, Collini P, Dei Tos AP, Flucke U, Hornick JL, Lobmaier I, Philippe T, Picci P, Ranchere D, Renne SL, Sbaraglia M, Thway K, Wagrodzki M, Wang WL, Yoshida A, Mariani L, Kawai A,Stacchiotti S. Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series. JAMA Oncol. 2018 Sep 1;4(9):e180219. doi:10.1001/jamaoncol.2018.0219. Epub 2018 Sep 13.
PubMed PMID: 29800950;
PubMed Central PMCID: PMC6143006.
Hompland I, Hølmebakk T, Boye K, Stoldt S, Bjerkehagen B, Berner JM, Wiedswang AM, Revheim ME, Poulsen JP, Hall KS, Bruland ØS. Multimodal kreftbehandling av gastrointestinal stromal tumor. Tidsskr Nor Laegeforen. 2018 Oct 1;138(15). doi: 10.4045/tidsskr.18.0200. Print 2018 Oct 2. Norwegian.
PubMed PMID: 30277049.
Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland ØS, Hall KS, Boye K Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study. Ann Surg Oncol. 2018 May;25(5):1133-1139. doi:10.1245/s10434-018-6353-5. Epub 2018 Feb 12.
PubMed PMID: 29435684.
Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K. Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour. Br J Surg. 2018 Dec 3. doi: 10.1002/bjs.11027. [Epub ahead of print]
PubMed PMID: 30507040.
Longhi A, Paioli A, Palmerini E, Cesari M, Abate ME, Setola E, Spinnato P,
Donati D, Hompland I, Boye K. Pazopanib in relapsed osteosarcoma patients: report on 15 cases. Acta Oncol. 2018 Sep 12:1-4. doi: 10.1080/0284186X.2018.1503714. [Epub ahead of print]
PubMed PMID: 30207179.
Namløs HM, Boye K, Mishkin SJ, Barøy T, Lorenz S, Bjerkehagen B, Stratford EW, Munthe E, Kudlow BA, Myklebost O, Meza-Zepeda LA. Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor. Mol Cancer Ther. 2018 Nov;17(11):2473-2480. doi: 10.1158/1535-7163.MCT-18-0174. Epub 2018 Aug 10.
PubMed PMID: 30097488.
Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K,
Bjerkehagen B, Hølmebakk T. Genotype and risk of tumour rupture in
gastrointestinal stromal tumour. Br J Surg. 2018 Jan;105(2):e169-e175. doi:10.1002/bjs.10743.
PubMed PMID: 29341147.
Casali PG, Bielack S, Abecassis N, Aro HT, Bauer S, Biagini R, Bonvalot S,
Boukovinas I, Bovee JVMG, Brennan B, Brodowicz T, Broto JM, Brugières L,
Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Dhooge C, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gaspar N, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hecker-Nolting S, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kager L, Kasper B, Kopeckova K, Krákorová DA, Ladenstein R, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Morland B, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA,
Schöffski P, Sleijfer S, Stacchiotti S, Strauss SJ, Sundby Hall K, Unk M, Van
Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee, PaedCan and ERN EURACAN. Bone sarcomas:ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment andfollow-up. Ann Oncol. 2018 Oct 1;29(Supplement_4):iv79-iv95. doi:10.1093/annonc/mdy310.
PubMed PMID: 30285218.
Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S,
Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky
O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct
1;29(Supplement_4):iv268-iv269. doi: 10.1093/annonc/mdy321.
PubMed PMID:30285214.
Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S,
Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A,Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL,Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S,Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, WhelanJ, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines fordiagnosis, treatment and follow-up. Ann Oncol. 2018 Oct 1;29(Supplement_4):iv267.doi: 10.1093/annonc/mdy320.
PubMed PMID: 30188977.
Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hannu A, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL,
Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S,
Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, Van der Graaf W, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct1;29(Supplement_4):iv68-iv78. doi: 10.1093/annonc/mdy095.
PubMed PMID: 29846513.
Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, DelMuro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S,Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL,Hannu A, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL,
Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S,
Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, Van der Graaf W, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN. Softtissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct1;29(Supplement_4):iv51-iv67. doi: 10.1093/annonc/mdy096. PubMed PMID: 29846498.
Ferrari S, Bielack SS, Smeland S, Longhi A, Egerer G, Sundby Hall K, Donati D, Kevric M, Brosjö O, Comandone A, Werner M, Monge O, Palmerini E, Berdel WE, Bjerkehagen B, Paioli A, Lorenzen S, Eriksson M, Gambarotti M, Tunn PU, Jebsen NL, Cesari M, von Kalle T, Ferraresi V, Schwarz R, Bertulli R, Kasparek AK, Grignani G, Krasniqi F, Sorg B, Hecker-Nolting S, Picci P, Reichardt P. EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma. Tumori. 2018 Jan-Feb;104(1):30-36. doi: 10.5301/tj.5000696.
PubMed PMID: 29218692.
Høland M, Kolberg M, Danielsen SA, Bjerkehagen B, Eilertsen IA, Hektoen M, Mandahl N, van den Berg E, Smeland S, Mertens F, Sundby Hall K, Picci P, Sveen A, Lothe RA. Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53. Mod Pathol. 2018 Jun 26. doi: 10.1038/s41379-018-0074-y. [Epub ahead of print] PubMed PMID: 29946184.
Ihle MA, Huss S, Jeske W, Hartmann W, Merkelbach-Bruse S, Schildhaus HU, Büttner R, Sihto H, Sundby Hall K, Eriksson M, Reichardt P, Joensuu H, Wardelmann E. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment. PLoS One. 2018 Feb 16;13(2):e0193048. doi: 10.1371/journal.pone.0193048. eCollection 2018.
PubMed PMID: 29451912;
PubMed Central PMCID: PMC5815598.
Stacchiotti S, Mir O, Le Cesne A, Vincenzi B, Fedenko A, Maki RG, Somaiah N, Patel S, Brahmi M, Blay JY, Boye K, Sundby Hall K, Gelderblom H, Hindi N, Martin-Broto J, Kosela H, Rutkowski P, Italiano A, Duffaud F, Kobayashi E, Casali PG, Provenzano S, Kawai A. Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma. Oncologist. 2018 Jan;23(1):62-70. doi:10.1634/theoncologist.2017-0161. Epub 2017 Jul 28.
PubMed PMID: 28754721;
PubMed Central PMCID: PMC5759809.
Sundby Hall K, Bruland ØS, Bjerkehagen B, Zaikova O, Engellau J, Hagberg O, Hansson L, Hagberg H, Ahlström M, Knobel H, Papworth K, Zemmler M, Goplen D, Bauer HCF, Eriksson M. Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX). Eur J Cancer. 2018 Aug;99:78-85. doi: 10.1016/j.ejca.2018.05.011. Epub 2018 Jun 19.
PubMed PMID: 29929092.
Panagopoulos I, Gorunova L, Lund-Iversen M, Andersen K, Andersen HK, Lobmaier I, Bjerkehagen B, Heim S. Cytogenetics of Spindle Cell/Pleomorphic Lipomas: Karyotyping and FISH Analysis of 31 Tumors. Cancer Genomics Proteomics. 2018 May-Jun;15(3):193-200.
PubMed PMID: 29695401;
PubMed Central PMCID: PMC5971011.
Panagopoulos I, Gorunova L, Andersen K, Lobmaier I, Bjerkehagen B, Heim S.Consistent Involvement of Chromosome 13 in Angiolipoma. Cancer Genomics Proteomics. 2018 Jan-Feb;15(1):61-65. PubMed PMID: 29275363; PubMed Central
PMCID: PMC5822184.
2017
Behjati S, Tarpey PS, Haase K, Ye H, Young MD, Alexandrov LB, Farndon SJ, Collord G, Wedge DC, Martincorena I, Cooke SL, Davies H, Mifsud W, Lidgren M, Martin S, Latimer C, Maddison M, Butler AP, Teague JW, Pillay N, Shlien A, McDermott U, Futreal PA, Baumhoer D, Zaikova O, Bjerkehagen B, Myklebost O, Amary MF, Tirabosco R, Van Loo P, Stratton MR, Flanagan AM, Campbell PJ. Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma.
Nat Commun. 2017 Jun 23;8:15936.
PMID: 28643781
Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K,
Bjerkehagen B, Hølmebakk T. Genotype and risk of tumour rupture in
gastrointestinal stromal tumour. Br J Surg. 2018 Jan;105(2):e169-e175. doi:
10.1002/bjs.10743. PubMed PMID: 29341147.
Boye K, Jebsen NL, Zaikova O, Knobel H,. Løndalen A, Trovik C, MongeOR, Hall KS Denosumab in patients with giant-cell tumor of bone in Norway; results from a nationwide cohort. Acta Oncol 2017 Mar;56(3):479-483. Doi:1080/0284186X.2016.1278305.
PMID:28105885
Davidson B, Micci F. Molecular characteristics of uterine sarcomas.
Expert Rev Mol Diagn. 2017 May;17(5):515-522. doi: 10.1080/14737159.2017.1311790. Review.
PMID:28335657
Ferrari S, Bielack SS, Smeland S, Longhi A, Egerer G, Sundby Hall K, Donati D, Kevric M, Brosjö O, Comandone Af, Werner M, Monge O, Palmerini E, Berdel WEi, Bjerkehagen B, Paioli A, Lorenzen S, Eriksson M, Gambarotti M, Tunn PU, Jebsen N, Cesari M, von Kalle T, Ferraresi V, Schwarz R, Bertulli R, Kasparek AK, Grignani G, Krasniqi F, Sorg B, Hecker-Nolting S, Picci R, Peter Reichardt
EURO.B.O.S.S.: A European chemotherapy study on chemotherapy in bone-sarcoma patients agewd over 40: Outcome in primary high-grade osteosarcoma. Tumori 2017; Dec 05. Epub 2017 des 5 PMID: 29218692
Hompland I, Bruland ØS, Hølmebakk T, Poulsen JPP, Stoldt S, Hall KS, Boye K Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort. Acta Oncol Accepted 2017 Oct; 56(10):1317-1323
PMID: 28557540
Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland Ø, Sundby Hall K, Boye K (2017). Recurrence-Free Survival after Resection of Gastric Gastrointestinal Stromal Tumors Classified according to a Strict Definition of Tumor Rupture: A Population-Based Study. Ann Surg Oncol. In press. PMID:29435684
Joensuu H, Wardelmann E, Sihto H, Eriksson M, Sundby Hall K, Reichardt A, Hartmann JT, Pink D, Ramadori G, Hohenberger P, Al-Batran SE, Schlemmer M, Bauer S, Junnila J, Vehtari A, Reichardt P. Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumor Treated With Adjuvant Imatinib: An Analysis of a Randomized Trial. JAMA oncology. 2017 May 1;3(5):602-609
PMID: 28334365
Konig M, Osnes TA, Lobmaier I, Bjerkehagen B, Bruland ØS, Sundby Hall K, et al. Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years. Neurosurgical review. 2017;40(3):449-60. PMID: 27858303
Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA 3rd, Oliva E, Young RH, Hensley ML, Leitao MM Jr, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Mod Pathol. 2017 Dec 1. doi: 10.1038/modpathol.2017.162.
PMID: 29192652
Micci F, Brunetti M, Dal Cin P, Nucci MR, Gorunova L, Heim S, Panagopoulos I.Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma.Genes Chromosomes Cancer. 2017 Dec;56(12):841-845. doi: 10.1002/gcc.22485. Epub 2017 Sep 6.
PMID: 28758277
Namløs HM, Zaikova O, Bjerkehagen B, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2017) Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report BMC Cancer, 17 (1), 29
PMID: 28061772
Norum OJ, Fremstedal ASV, Weyergang A, Golab J, Berg K. Photochemical delivery of bleomycin induces T-cell activation of importance for curative effect and systemic anti-tumor immunity. J Control Release. 2017 Dec 28;268:120-127. doi: 10.1016/j.jconrel.2017.10.015. Epub 2017 Oct 16.
PMID: 29042319
Olsen CE, Sellevold S, Theodossiou T, Patzke S, Berg K.
Impact of genotypic and phenotypic differences in sarcoma models on the outcome of photochemical internalization (PCI) of bleomycin.
Photodiagnosis Photodyn Ther. 2017 Dec;20:35-47. doi: 10.1016/j.pdpdt.2017.08.010. Epub 2017 Aug 23.
PMID:28838761
Panagopoulos I, Gorunova L, Brunetti M, Agostini A, Andersen HK, Lobmaier I, Bjerkehagen B, Heim S (2017) Genetic heterogeneity in leiomyomas of deep soft tissue
Oncotarget 2017 Jul 25;8 (30), 48769-48781
PMID: 28591699
Panagopoulos I, Gorunova L, Lobmaier I, Andersen HK, Bjerkehagen B, Heim S (2017) Cytogenetic Analysis of a Pseudoangiomatous Pleomorphic/Spindle Cell Lipoma. Anticancer Res, 37 (5), 2219-2223.
PMID: 28476785
Panagopoulos I, Gorunova L, Lobmaier I, Bjerkehagen B, Heim S (2017) Identification of SETD2-NF1 fusion gene in a pediatric spindle cell tumor with the chromosomal translocation t(3;17)(p21;q12)
Oncol Rep, 37 (6), 3181-3188.
PMID: 28498454
Panagopoulos I, Gorunova L, Lobmaier I, Bjerkehagen B, Heim S (2017) Karyotyping and analysis of GNAS locus in intramuscular myxomas
Oncotarget, 8 (13), 22086-22094
PMID: 28160572
Panagopoulos I, Gorunova L, Bjerkehagen B, Andersen K, Lund-Iversen M, Heim S (2017) Loss of chromosome 13 material in cellular angiofibromas indicates pathogenetic similarity with spindle cell lipomas
Diagn Pathol, 12 (1), 17.
PMID: 28193293
Pulkka OP, Nilsson B, Sarlomo-Rikala M, Reichardt P, Eriksson M, Sundby Hall K, Wardelmann E, Vehtari A, Joensuu H, Sihto H. SLUG Transcription Factor: A pro-survival and prognostic factor gastrointestinal stromal tumor. Br.J Cancer 2017 Apr 25;116(9):1195-1202.doi:10.1038/bjc.2017.82. PMID 28334729
Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA, Hagene KT, Aas E, Lurås H, Johnsen-Soriano S, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Mælandsmo GM, Flatmark K (2017). Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate.
ESMO Open. 2(2)
PMID: 28761742
Serguienko A, Hanes R, Grad I, Wang MY, Myklebost O, Munthe E. PP2A Regulatory Subunit B55γ is a Gatekeeper of Osteoblast Maturation and Lineage Maintenance.
Stem Cells Dev. 2017 Oct 1;26(19):1375-1383. doi: 10.1089/scd.2017.0129. Epub 2017 Aug 10.
PMID: 28805158
Strøm NJ, Pripp AH, Reikerås O. Templating in uncemented total hip arthroplasty-on intra- and interobserver reliability and professional experience
Ann Transl Med. 2017 Feb;5(3):43
PMID:28251122
Trovik C, Bauer HCF, Styring E, Sundby Hall K, Vult Von Steyern F, Eriksson S, Johansson I, Sampo M, Laitinen M, Kalén A, Jónsson H, Jebsen N, Eriksson M, Tukiainen E, Wall N, Zaikova O, Sigurðsson H, Lehtinen T, Bjerkehagen B, Skorpil M, Egil Eide G, Johansson E, Alvegard TA (2017) The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma
Acta Orthop, 88 (3), 341-347.
PMID:28266233
Sellevold S, Peng Q, Fremstedal ASV, Berg K.
Photochemical internalization (PCI) of bleomycin is equally effective in two dissimilar leiomyosarcoma xenografts in athymic mice. Photodiagnosis and Photodynamic Therapy 20 (2017) 95–106 doi: 10.1016/j.pdpdt.2017.08.015. Epub 2017 Sep 1.
PMID:28865875
Pugdahl K, Johnsen B, Tankisi H, Camdessanché JP, de Carvalho M, Fawcett PRW, Labarre-Vila A, Liguori R, Nix W, Schofield I, Fuglsang-Frederiksen A. Addedvalue of electromyography in the diagnosis of myopathy: A consensus exercise. Clin Neurophysiol. 2017 May;128(5):697-701. doi: 10.1016/j.clinph.2017.02.001.
Epub 2017 Feb 15.
PubMed PMID: 28315611.